Cipla collaboration brings a second brand of tirzepatide, Yurpeak, to India, aiming to widen patient access for diabetes and ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
Eli Lilly's launch of Mounjaro in India in March 2025 was the first step of Tirzepatide in the country. In June 2025, the ...
Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage ...
Cipla enters obesity and diabetes drug market with Eli Lilly's tirzepatide 'Yurpeak'; Nuvama retains 'Hold' on Cipla stock, ...
Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...
Eli Lilly said on Wednesday its experimental pill, orforglipron, helped reduce blood sugar levels in two late-stage trials.
A Lilly experimental weight loss pill showed superior blood sugar control in diabetic patients across two late-stage clinical ...
KELOWNA, BC / ACCESS Newswire / March 18, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to ...
The United Kingdom's healthcare regulator on Friday said it had made the world's largest seizure of illegal weight loss ...
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) seized the world's largest cache of unlicensed ...
Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback